Navigation Links
Genetic pattern that predicts leukemia relapse discovered
Date:5/11/2010

A genetic pattern that predicts the likelihood of relapse in patients with one of the most aggressive forms of childhood leukemia has been discovered. Researchers publishing in the open access journal Molecular Cancer have identified a consistent pattern in five genes that has the potential to enable doctors to identify which patients would benefit from more aggressive treatment when first diagnosed with T-cell acute lymphoblastic leukemia (T-ALL).

Co-author Dr Alex Beesley of Perth's Telethon Institute for Child Health Research said "While up to 80% of children with T-ALL achieve complete remission, there are around 20% who relapse and whose prognosis can be very poor," Dr Beesley said. "In this study, we found a consistent pattern in the expression of five genes in patients that relapse. Importantly, this pattern was found to hold true across multiple patient cohorts, the first time that such a robust gene signature of this kind has been found for T-ALL. This gene signature would enable patients with T-ALL to be classified according to risk at the time of diagnosis."

Dr Beesley said the discovery had significant potential to improve outcomes for patients at high risk of relapse. "Patients identified using these markers could potentially be treated with more aggressive therapies from the outset to give them the best hope of achieving complete remission."

The research team analyzed bone marrow samples from children treated under the international Children's Oncology Group (COG) protocols.

They used gene-profiling (microarray) technology to model a five-gene classifier that accurately predicted clinical outcome in a cohort of 50 T-ALL patients. The five-gene classifier was further tested against three independent cohorts of T-ALL patients, using two different techniques (either quantitative RT-PCR or microarray gene expression), and could predict patients with significantly adverse clinical outcome in each.

Dr Beesley said the study also provided clues to the biological mechanisms leading to relapse in T-ALL, which could ultimately identify potential targets for new therapies to the disease.

T-ALL affects approximately 15% of newly diagnosed pediatric leukemia patients. The prognostic potential of the gene markers identified from this research will now be investigated as part of a large international Children's Oncology Group study of T-ALL patients undergoing the latest therapy.


'/>"/>

Contact: Charlotte Webber
charlotte.webber@biomedcentral.com
44-020-319-22219
BioMed Central
Source:Eurekalert

Related medicine news :

1. Resveratrol Supplement Company RevGenetics Welcomes New Chief Science Officer
2. Genetic Variants Tied to MS, Study Finds
3. UT Southwestern participates in nationwide study offering free lung tumor genetic testing
4. Genetic Research Sheds Light on Chronic Pain
5. High doses of antioxidant supplements induce stem cell genetic abnormalities
6. New research about human genetic diseases and human development
7. Genetics, Psychology May Trigger ADHD
8. Plant pathogen genetically tailors attacks to each part of host, say Stanford researchers
9. Study finds changes in fetal epigenetics throughout pregnancy
10. Lab that probes genetic clues to disease is poised for major expansion
11. Single Genetic Factor Key to Cardiovascular System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: